4th Quarter - Report

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Firm
Client
Income
—
Expenses
$1,320,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to the tax treatment of nonprofits, deductability of charitable donations, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY14 Budget.

LobbyistCovered position, as disclosed
GREGG HAIFLEY —
VICTORIA SENG —
RICHARD WOODRUFF —

Contacted: Environmental Protection Agency (EPA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); White House Office; Labor, Dept of (DOL)

Health Issues HCR

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care andHospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.3404, the Breast Density & Mammography Reporting Act.

LobbyistCovered position, as disclosed
SARAH BOGDAN —
OKEYSHA BROOKS-COLEY —
ROBERT CHAPMAN —
GREGG HAIFLEY —
GRETA JOHNSON —
PATRICIA MALLIOS —
MATTHEW PHELAN —
DAVID PUGACH —
SARA SAHLI Staff member for U.S. Senator
VICTORIA SENG —
MONA SHAH —
RICHARD WOODRUFF —

Contacted: U.S. Agency for International Development (USAID); White House Office; Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: S. 621 (113th), H.R. 2607 (113th), H.R. 2019 (113th), H.R. 3404 (113th), S. 1251 (113th), S. 1247 (113th), S. 641 (113th), S. 881 (113th), H.R. 1851 (113th), H.R. 1666 (113th), H.R. 460 (113th), H.R. 2058 (113th), H.R. 1339 (113th)

Medicare/Medicaid MMM

Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS "value-based purchasing", general deficit reduction issues impacting Medicare & Medicaid, and H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013; H.R.2810, Medicare Patient Access & QualityImprovement Act and S.1871, the SGR Repeal & Medicare Beneficiary Access Act.

LobbyistCovered position, as disclosed
SARAH BOGDAN —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
PATRICIA MALLIOS —
MATTHEW PHELAN —
VICTORIA SENG —
MONA SHAH —
RICHARD WOODRUFF —

Contacted: Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); White House Office; Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID)

Bills named: H.R. 1070 (113th), H.R. 2810 (113th), S. 1871 (113th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, and international health. S.1284, the FY14 Labor, Health & Human Resources Appropriations Act; H.J.Res.59, Continuing Resolution; H.R.2775, Continuing Appropriations; and H.R.3547,Omnibus Appropriations for FY14, and matters relating to the impact of the government-wide sequester as it affects CDC, NIH, NCI, Prevention & Public Health Fund, and other appropriated accounts relating to cancer.

LobbyistCovered position, as disclosed
SARAH BOGDAN —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
PATRICIA MALLIOS —
MATTHEW PHELAN —
DAVID PUGACH —
SARA SAHLI Staff member for U.S. Senator
VICTORIA SENG —
MONA SHAH —
RICHARD WOODRUFF —

Contacted: Environmental Protection Agency (EPA); White House Office; U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS)

Bills named: H.R. 2775 (113th), H.J.Res. 59 (113th), H.R. 3547 (113th), S. 1284 (113th)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31): (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC). S.39, Healthy Lifestyles and Prevention America Act, H.R.792 & S.772, cigar exemptionfrom FDA regulations; S.194, Tobacco Tax Equity Act and tobacco tax proposals contained in the President's FY14 Budget. Issues relating to tobacco and trade, including the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership, and legislation relating to trade promotion authority.

LobbyistCovered position, as disclosed
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
PATRICIA MALLIOS —
MATTHEW PHELAN —
DAVID PUGACH —
SARA SAHLI Staff Member for U.S. Senator
VICTORIA SENG —
MONA SHAH —
RICHARD WOODRUFF —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL)

Bills named: S. 194 (113th), S. 772 (113th), H.R. 792 (113th), S. 39 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.